Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2 results

  • Chapter 9 - Alternative modes of treatment: pulsatile estradiol treatment

  • from Section 2 - Varieties of estrogenic therapy
  • Edited by Eef Hogervorst, Loughborough University, Victor W. Henderson, Stanford University, California, Robert B. Gibbs, University of Pittsburgh, Roberta Diaz Brinton, University of Southern California
  • Book:
    Hormones, Cognition and Dementia
    Published online:
    06 July 2010
    Print publication:
    24 September 2009, pp 87-92

  • Summary

    Editors' introduction

    It is increasingly clear that not all estrogenic treatment regimens are alike with respect to effects on the brain, and that alternative regimens need to be evaluated and compared. In this chapter, Li and Al-Azzawi discuss the advantages of intranasal pulsatile estradiol administration relative to oral or transdermal therapies. Pharmacokinetic analyses demonstrate the feasibility of using intranasal pulsatile estradiol treatments to produce estradiol exposures comparable to those achieved via a transdermal route. As with transdermal therapies, intranasal application avoids the negative effects on liver enzymes associated with oral treatment. Major differences in the effects of pulsatile vs. sustained estradiol administration on gene expression have been detected. In addition, there are noted potential advantages of pulsatile vs. sustained treatment such as up-regulation of estrogen receptors, initialization of estrogen receptor co-factors, repeated activation of non-genomic pathways, and lower levels of potentially active (and carcinogenic) metabolites.